SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — Katharine Hepburn

PatientKatharine Hepburn
Date of birth1953-05-12
IdentifiersMRN HR-ML012-SYN; SSN (made up) 000-12-8834
Document date2026-08-04
AuthorGwendolyn Price, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month tremor review. [S]

History of Present Illness

Ms. Hepburn returns six months after her first visit. She continues propranolol extended-release 60 mg each morning with no missed doses and no lightheadedness, wheeze, tiredness, or low mood. The hands remain steadier than in the winter; the head tremor is unchanged and does not trouble her. She uses the voice strategies on stage. She has had no falls. The occupational therapy evaluation that was to be booked after the last visit was not arranged, and it is now booked for two weeks from today. [S]

ElementDetail
MedicinePropranolol extended-release 60 mg daily; no side effects
TremorHands steadier; head tremor unchanged
FallsNone in six months
Occupational therapyNot yet seen; booked for two weeks from today

Review of Systems

SystemResultFinding
NeurologicalPositiveMild hand tremor and unchanged head tremor; no stiffness, slowness, or imbalance
RespiratoryNegativeNo wheeze
CardiovascularNegativeNo lightheadedness on standing or fainting
PsychiatricNegativeMood good

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Propranolol extended-release 60 mg oral capsule, one capsule by mouth once dailyOne capsule by mouth each morningOral route2026-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-04Body height170cmS
2026-08-04Body weight56.3kgS
2026-08-04Body mass index (BMI) [Ratio]19.5kg/m2S
2026-08-04Systolic blood pressure124mm[Hg]S
2026-08-04Diastolic blood pressure74mm[Hg]S
2026-08-04Heart rate62/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.6CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-08-04; see the Vital Signs section. [S]

SystemFinding
GeneralAlert and energetic
CardiovascularRegular rhythm at 62 per minute. Blood pressure 124/74 mmHg seated and 120/72 mmHg after 3 minutes standing, without symptoms; no orthostatic drop
NeurologicalTETRAS performance subscale 15; daily-living subscale 8. Mild postural and kinetic hand tremor; head tremor unchanged; no rest tremor, bradykinesia, or rigidity; tandem gait normal
GaitSteady; Timed Up and Go not repeated, due at the wellness visit

Problems

ProblemClinical statusVerificationCodeProvenance
Essential tremor: bilateral upper-limb action tremor with head (no-no) and voice tremor, without other neurological signsactiveprovisional G25.0S — Synthetic modern coding of her publicly visible tremor; the label is a retrospective interpretation (R), so verification is provisional. Severity scores are synthetic.
Voice tremor due to essential tremor, mild, with a wavering pitch on sustained vowelsactiveconfirmed R49.8S — Synthetic modern coding anchored to public descriptions of her quivery voice; the severity at the index age is synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationTremor rating: TETRAS performance and activities of daily living subscalesEvery visitCompleted todayPerformance subscale 15; daily-living subscale 8
ExaminationArchimedes spiral drawing and handwriting sampleEvery visitCompleted todaySmall tremor waves; handwriting steady
ExaminationExamination for signs beyond tremor (rest tremor, bradykinesia, rigidity, dystonia, ataxia, cognitive change)At diagnosis, then yearly or with a change in the tremorUp to dateNo signs beyond tremor today; yearly neurology review due in the winter
ExaminationResting heart rate and seated and 3-minute standing blood pressureEvery visit on a beta-blockerCompleted todayPulse 62; 124/74 mmHg seated and 120/72 mmHg standing; the standing check missed at three months was done today
Medication safetyBeta-blocker safety: wheeze, slow pulse or heart block, fatigue, cold hands, low mood, hypoglycemia awarenessEvery visitCompleted todayNo side effects
Medication safetyPrimidone safety: sedation, unsteadiness, nauseaEvery visit on primidoneNot indicatedNot on primidone
Medication safetyDrugs and substances that worsen tremor (beta-agonists, valproate, lithium, antidepressants, excess thyroid hormone, caffeine)Every visitCompleted todayNo new medicines
ExaminationFall query, with Timed Up and Go yearlyEvery visitCompleted todayNo falls in six months; Timed Up and Go due at the wellness visit
SurveyMood (PHQ-9)Before a beta-blocker, after starting it, then yearlyUp to datePHQ-9 3 three months ago; mood good today
LaboratoryTSH and basic chemistry to exclude metabolic causesOnce at diagnosis; again only with a change in the tremorUp to dateNormal at diagnosis
ReferralSpeech-language therapy for voice tremorWhen voice tremor affects speech or workUp to dateCourse completed; strategies in use
ReferralOccupational therapy for adaptive aidsWhen tremor limits daily tasksDeferredRecommended at the four-week visit but not booked for five months, a deviation from the plan. She managed by carrying cups half full and limiting writing, with no injury or loss of independence. Corrective action: the evaluation is booked for two weeks from today, and referrals are now tracked to completion
Medication safetyBotulinum toxin for head or voice tremorIf head or voice tremor is disablingNot indicatedHead and voice tremor not disabling
ReferralReferral for focused ultrasound thalamotomy or deep brain stimulationIf disabling limb tremor persists after adequate trials of propranolol and primidoneNot indicatedGood response to propranolol; no disabling tremor
SurveyCognitive screen (MoCA)YearlyUp to dateMoCA 28 seven months ago
Medication safetyAGS Beers Criteria medication reviewYearly from age 65Up to dateNo new medicines
Self-managementAdvance care planning and goals of careAt least yearly from 65DueAt the annual wellness visit in two months
Self-managementVaccination status (influenza, pneumococcal, zoster, COVID-19, Tdap)Yearly, per the CDC scheduleDueInfluenza, pneumococcal, and zoster vaccines at the wellness visit

Goal progress:

Guideline basis: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2005); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018); MDS evidence-based review of treatments for essential tremor (2019); CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026)

Follow-up: Occupational therapy in two weeks. Annual wellness visit in two months. Tremor review in about six months. Next scheduled visit 2026-10-06: subsequent annual wellness visit. [S]